A real-world analysis of adverse events and operational impacts of using T-cell engager therapy in an oncology setting.

Fernandes S, Nijjar D, Rahaman L, Farley S, Delawala S.

Open source

DOI
10.5737/23688076362350
Published
2026-05-01
Container
Can Oncol Nurs J
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.5737/23688076362350,
  title = {A real-world analysis of adverse events and operational impacts of using T-cell engager therapy in an oncology setting.},
  author = {Fernandes S and  Nijjar D and  Rahaman L and  Farley S and  Delawala S.},
  year = {2026},
  journal = {Can Oncol Nurs J},
  doi = {10.5737/23688076362350},
  url = {https://doi.org/10.5737/23688076362350}
}

RIS

TY  - JOUR
TI  - A real-world analysis of adverse events and operational impacts of using T-cell engager therapy in an oncology setting.
AU  - Fernandes S
AU  -  Nijjar D
AU  -  Rahaman L
AU  -  Farley S
AU  -  Delawala S.
PY  - 2026
JO  - Can Oncol Nurs J
DO  - 10.5737/23688076362350
UR  - https://doi.org/10.5737/23688076362350
ER  - 

APA

S, F., D, N., L, R., S, F., & S., D. (2026). A real-world analysis of adverse events and operational impacts of using T-cell engager therapy in an oncology setting.. Can Oncol Nurs J. https://doi.org/10.5737/23688076362350

Source records